Related Experiment Video

Updated: Jun 25, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Autophagy: a strategy for malignant gliomas' resistance to therapy

Pengfei Ge1, Yinan Luo, Shuanglin Fu

  • 1Neurosurgery Department, Xuanwu hospital, Capital University of Medical Science, 45 Changchun Street, Beijing 100053, PR China.

Medical Hypotheses
|March 10, 2009
PubMed

Insights

Autophagy, a cellular recycling process, may help malignant gliomas resist chemotherapy and radiotherapy. Further research is needed to confirm if targeting autophagy can improve brain tumor treatment outcomes.

Area of Science:

  • Neuro-oncology
  • Cellular Biology
  • Cancer Research

Background:

  • Malignant gliomas are aggressive primary brain tumors associated with high morbidity.
  • These tumors exhibit significant resistance to conventional therapies like chemotherapy and radiotherapy, with unclear underlying mechanisms.
  • Autophagy is a fundamental cellular process involving the degradation of cellular components via lysosomes, crucial for cell survival under stress.

Purpose of the Study:

  • To investigate the potential role of autophagy in the therapeutic resistance of malignant gliomas.
  • To explore autophagy as a novel therapeutic target for improving treatment efficacy in brain tumors.

Main Methods:

  • Review of current experimental findings on autophagy in cancer.
  • Hypothesis formulation based on observed correlations between autophagy and tumor cell survival.

Main Results:

  • Emerging evidence suggests autophagy promotes tumor cell survival in challenging environments, including nutrient deprivation and during therapy.
  • Autophagy's role in enabling malignant glioma cells to withstand chemotherapy and radiotherapy is increasingly recognized.

Conclusions:

  • Autophagy is hypothesized to be a key factor contributing to the therapy resistance observed in malignant gliomas.
  • While the precise effects of autophagy on glioma cell fate require further elucidation, it presents a promising new avenue for understanding and potentially overcoming treatment resistance in these brain tumors.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...